Libya Serialization and Traceability Compliance

Discover OneScan

Global Regulations

Icon graphic element
Labelling

Products are required to display information in writing.

Graphic element
Unit Level Traceability

Sellable units are uniquely identified enabling a more granular traceability.

Summary

Pharmaceutical products in Libya are regulated by the Libyan Ministry of Health and the Libyan National Center for Food and Drug Control (NCFDC). The regulatory framework focuses on ensuring medicine quality, preventing counterfeit products, and strengthening oversight of pharmaceutical imports and distribution.

Libya has introduced initiatives to improve medicine authentication and supply chain monitoring, including the use of barcode based product identification on pharmaceutical packaging. These measures are intended to support verification of medicines distributed within the country and improve regulatory monitoring.

However, Libya does not currently operate a fully implemented national pharmaceutical serialization or track and trace system. Regulatory oversight relies primarily on medicine registration, import control, and inspection of distribution channels.

Pharmaceutical companies supplying medicines to Libya should monitor regulatory developments, as authorities have expressed interest in expanding digital traceability mechanisms in the future.

Labelling Requirements 

Pharmaceutical products distributed in Libya must comply with labeling requirements defined by the Ministry of Health and the National Center for Food and Drug Control.

Packaging must include standard pharmaceutical identification elements such as:

  • Product name and dosage strength
  • Batch or lot number
  • Expiry date
  • Manufacturer information
  • Registration details

Barcodes may be included on pharmaceutical packaging to support product identification and supply chain management, but unit level serialization using DataMatrix codes is not currently mandated by Libyan regulations.

Regulatory Timeline 

2000s onward
Libya strengthened pharmaceutical regulatory oversight through the establishment of the National Center for Food and Drug Control.

Recent years
Authorities have increased efforts to combat counterfeit medicines and improve monitoring of pharmaceutical imports and distribution.

Current Status
Libya has not yet implemented a mandatory pharmaceutical serialization or national traceability program.

Reporting Requirements 

Since serialization is not currently mandated, Libya does not require reporting of serialized pharmaceutical product events such as commissioning, shipment, receipt, or dispensing.

Pharmaceutical companies must instead maintain standard documentation related to product registration, importation, and distribution that can be reviewed during regulatory inspections.

Reporting Hub

Libya does not currently operate a national pharmaceutical serialization reporting platform.

Regulatory oversight is managed through systems and procedures operated by:

  • The Libyan Ministry of Health
  • The National Center for Food and Drug Control

These authorities oversee medicine registration, import authorization, and market surveillance activities but do not currently require electronic reporting of serialized pharmaceutical product movements.

Aggregation Requirements 

Libyan pharmaceutical regulations do not require aggregation or hierarchical packaging identification for medicines.

Companies may implement internal aggregation practices for logistics or export compliance, but these practices are not mandated by national regulatory authorities.

Other Information

Operational Considerations for Industry

  • Ensure medicines are properly registered with Libyan regulatory authorities before importation.
  • Maintain accurate documentation for pharmaceutical imports and distribution.
  • Apply barcodes or identification systems when required by supply chain partners or international export regulations.
  • Monitor future regulatory developments related to pharmaceutical traceability initiatives.

‍

Common Misconceptions

  • Assuming Libya has implemented a mandatory pharmaceutical serialization system.
  • Expecting a centralized national traceability platform similar to those used in the European Union or GCC markets.
  • Implementing serialization solely for Libyan regulatory compliance without confirming regulatory requirements.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us